BPG is committed to discovery and dissemination of knowledge
Featured Articles
8/29/2018 4:56:27 AM | Browse: 620 | Download: 580
 |
Received |
|
2018-05-31 01:17 |
|
Peer-Review Started |
|
2018-05-31 02:58 |
|
To Make the First Decision |
|
2018-06-21 00:56 |
|
Return for Revision |
|
2018-07-04 08:31 |
|
Revised |
|
2018-07-06 01:33 |
|
Second Decision |
|
2018-07-13 08:35 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2018-07-16 01:38 |
|
Articles in Press |
|
2018-07-16 01:38 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-08-27 01:40 |
|
Publish the Manuscript Online |
|
2018-08-27 07:22 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Amporn Atsawarungruangkit, Jirat Chenbhanich and George Dickstein |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Amporn Atsawarungruangkit, BPharm, MD, Doctor, Research Fellow, Department of Medicine, MetroWest Medical Center, 115 Lincoln St., Framingham, MA 01702, United States. a.atsawarungruangkit@mwmc.com |
| Key Words |
Insulin resistance; Fatty liver; Hepatosteatosis; Metabolic syndrome; C-peptide |
| Core Tip |
Non-alcoholic fatty liver disease (NAFLD) is a growing global epidemic and associated with many conditions and factors, including insulin resistance. However, C-peptide has not been used in practice to assess insulin resistance in NAFLD patients. Using a large national dataset, we demonstrated that three most important risk factors for NAFLD are waist circumference, fasting C-peptide, and alanine aminotransferase, respectively. Such results revealed that C-peptide superior to measurement of fasting insulin levels and can potentially be used for screening or monitoring the degree of insulin resistance in NAFLD. |
| Publish Date |
2018-08-27 07:22 |
| Citation |
Atsawarungruangkit A, Chenbhanich J, Dickstein G. C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population. World J Gastroenterol 2018; 24(32): 3663-3670 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i32/3663.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i32.3663 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
